Logo

Nuvelo, Orchid, Illumina, Oscient Among 26 Additions to Nasdaq Biotech Index

May 18, 2004

NEW YORK, May 18 (GenomeWeb News) - Several genomics companies, including Nuvelo, Orchid, Illumina, and Oscient (formerly Genome Therapeutics), were among 26 securities added to the Nasdaq Biotechnology Index yesterday.

The change in the index will become effective with the market open next Monday.

The Nasdaq stock market re-ranks the index every May and November based on minimum requirements for market value, average daily share volume, and other criteria.

A full list of the new firms added to the index is available here.

Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.